
How do I evaluate what you're actually buying — in the aisle that sells 'blood builders' next to the mineral with a toxicity ceiling?
The blood aisle runs the estate's sharpest split: its most legitimate products (iron, B12 — the raw materials of a correctable deficiency) share shelf space with the trend claims that evaporate on contact with a lab — chlorophyll 'plant blood' drops (structural marketing: the molecule with magnesium where iron belongs), 'blood cleanses,' 'oxygen boosters,' and the 'energy iron' blends sold to populations whose fatigue was never iron. Evaluation here is one question, asked ruthlessly: where is the lab value? Blood's endpoints are the hardest in nutrition — hemoglobin, ferritin, reticulocytes — and every honest product in this category either sits downstream of those numbers or admits it doesn't belong in the category at all.
The tolerated form — lab-gated
5000 mcg — the passive route
The pairing, timed
The structure-marketing trend
Iron chelated to glycine — well absorbed with a fraction of sulfate's constipation and dyspepsia (the form our iron page's ladder crowns). The form that lets the correction dose actually be taken — adherence is pharmacology's first cousin.
Ferrous sulfate: the studied classic, absorbed but GI-costly. Ferrous oxide: the cheap form, poorly absorbed — the zinc/magnesium oxide lesson, iron edition. And the elemental-math rule: labels state elemental iron (the absorbable amount) — 25 mg bisglycinate and 325 mg sulfate deliver different letters entirely.
Label literacy in the blood aisle has four specific jobs:
The blood market sells 'energy' — the most universal complaint in medicine — to an audience that hasn't run labs. Be highly cautious of products that: